<DOC>
	<DOCNO>NCT01512459</DOCNO>
	<brief_summary>The objective study compare relative bioavailability Venlafaxine MR Capsules 150 mg Effexor XR Capsules 150 mg Fed condition healthy adult human subject .</brief_summary>
	<brief_title>Bioavailability Study Venlafaxine MR Capsules 150 mg Under Fed Conditions</brief_title>
	<detailed_description>An open labeL balance , randomize , two-treatment . two-period , two-sequence , single dose , crossover , evaluation relative bioavailability Venlafaxine 150 mg ( HCl salt ) MR capsule Dr. Reddy 's compare Effexor XR ( contain Venlafaxine 150 mg ( HCl salt ) capsule wyeth Laboratories , Philadelphia , PA , USA healthy human subject feed condition .</detailed_description>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Subjects must fulfill follow criterion consider inclusion study : Subjects provide write informed consent . Subjects must healthy human being within 1845 year age ( inclusive ) weigh least 50 kg . Having Body mass Index ( BMI ) 18.5 24.9 ( inclusive ) , calculate weight Kg/height m2 Subjects must normal health determine medical history physical examination perform within 21days prior commencement study . Subjects whose screen laboratory value within normal limit consider physician/investigator clinical significance . Have normal ECG , Xray vital sign . Availability subject entire study period willingness adhere protocol requirement evidence write informed consent . Subjects incapable understanding informed consent . Subjects : Systolic blood pressure le 90 mm Hg 140 .mm Hg Diastolic blood pressure le 60 mm Hg 94 mm Hg . Minor deviation ( 24 mm Hg ) checkin may acceptable discretion physician/investigator . Pulse rate 50/min 100/min . History hypersensitivity idiosyncratic reaction Venlafaxine relate drug . Any evidence impairment renal , hepatic , cardiac , lung gastrointestinal .function . Consumption grapefruit past ten day prior dose day completion study . Regular smoker habit smoke nine cigarette per day difficulty abstain smoke 48 hour dose completion study . Subjects take counter prescribe medication last 7 day date study . Subjects take enzyme modify drug systemic medication within past 30 day prior start clinical study History psychiatric illness , may impair ability provide write , informed consent . Subjects clinically significant abnormal value laboratory parameter . Subjects participate clinical investigation use experimental drug bleed 330 mL past 90 day date start study . Subjects positive screen drug abuse alcohol . Any subject Venlafaxine contraindicate medical reason . Any subject recent history surgery A history difficulty donate blood . A positive test result HIV antibody and/or syphilis A recent history alcoholism ( &lt; 2 year ) moderate ( 180 ml/day ) alcohol use , consumption alcohol within 48 hr prior receive Investigational Product . Female subject pregnant able ( woman child bear potential ) become pregnant study allow participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Bioavailability</keyword>
	<keyword>Venlafaxine</keyword>
	<keyword>two way crossover</keyword>
</DOC>